期刊文献+

血小板聚集功能临床应用进展 被引量:1

Clinical Application Progress of Platelet Aggregative Function
下载PDF
导出
摘要 血小板具有凝血和止血的功能.血小板聚集率在一定程度上能预示患者的出血风险,故对患者进行血小板功能试验的检测对临床治疗和患者出血风险评估方面有着重要的意义.血小板聚集功能的测定对于临床上诊断出血性疾病、血栓前状态、血栓性疾病及抗血小板药物监测方面具有重要意义.血小板聚集率检测在血液病、心内科疾病、神经内科疾病、内分泌科疾病及其并发症的预防、抗凝药物的监测、疾病辅助诊断和预后发挥着积极的作用.因此开展血小板聚集功能检测技术是临床不可缺少的项目之一. Platelet has the function of blood coagulation and hemostasis.The platelet aggregation rate,to a certain extent,can predict patients bleeding risk.So the detection of platelet function has an important meaning in the clinical treatment and the risk assessment of patients bleeding.Detection of platelet aggregation function plays a positive role in the clinical diagnosis of hemorrhagic disease,prethrombotic state,thrombotic diseases and antiplatelet drug monitoring.The function of platelet aggregation plays a positive role in blood diseases,heart diseases,neurology disease,endocrine diseases,and the prevention of complications,monitoring of anticoagulant drugs,diseases auxiliary diagnosis and prognosis.Therefore,carrying out the detection of platelet aggregation function is one of the indispensable items in clinical treatment.
出处 《内蒙古民族大学学报(自然科学版)》 2014年第6期700-702,共3页 Journal of Inner Mongolia Minzu University:Natural Sciences
基金 内蒙古民族大学科学研究项目(NMD1348)
关键词 血小板聚集率 临床应用 Platelet aggregation rate Clinical application
  • 相关文献

参考文献10

二级参考文献26

  • 1Jawahar L Mehta,Bhavna Mohandas.Aspirin resistance: Fact or fiction? A point of view[J].World Journal of Cardiology,2010,2(9):280-288. 被引量:7
  • 2葛宁,姜建,王海,彭先镜.老年非瓣膜心房纤颤合并脑梗塞患者血小板活化状态的研究[J].四川大学学报(医学版),2004,35(5):729-730. 被引量:6
  • 3[1]Gawaz M, Ott I, Neumann FJ. Surface expression of platelet membrane glycoproteins following coronary stenting: effect on subacute stent thrombosis. Circulation, 1994,90:552.
  • 4[2]Neumann FJ, Gawaz M, Ott I, et al. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary PalmazSchatz stenting. J Am Coll Cardiol, 1996,27:15.
  • 5[3]HankeH, StrohschneiderT, OberhoffM, etal. Time coures of smooth muscle cell proliferation in intima of arteries following experimental angioplasy. Circ Res, 1990,61:651.
  • 6[4]Plow EF, Cinsberg MH. GP Ⅱ b/Ⅲ a as a prototypic adhesion receptor.Prog Hemost Thromb, 1989,9:117.
  • 7[5]The EPIC Investigators. Usc of a monoclonal antibody directed against the platelet glycoprotein Ⅱ b/Ⅲ a receptor in high-risk coronary angioplasty. N Engl J Med, 1994,330:981.
  • 8J.W.Yarnell,J.A.Baker,et al.Fibrinogen,viscosity and white blood cell are major risk factors for ischemic heart disease.The Caerphilly and Speedwell collaborative heart disease studies[J].Circulation,1991,83:836~844.
  • 9O.K. Baskurt,E.Levi,S.Caglayan,et al.The role of hem-orheologic factors in the coronary circulatiom[J].Clin,Hemorheol,1991,11:121~127.
  • 10K.Toth,G.Kesmarky,L.Habon,et al.Hemorheology and hem-odynamics:A complex approach to the coronary circulation and development of myocardial ischemia[A].In:S.G.Sajjadi,G.B.Nash,N.W.Rampling,eds.Cardiovascular Flow Modelling and Measurement with Application Medicine[M].Oxford University press,Oxford,1999.163~174.

共引文献15

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部